0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Mono Vaccine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: September 2024
|
Report Code: QYRE-Auto-10L12235
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Mono Vaccine Industry Research Report Growth Trends and Competitive Analysis 2022 2028
BUY CHAPTERS

Mono Vaccine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-10L12235
Report
September 2024
Pages:99
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Mono Vaccine - Market Size

The global market for Mono Vaccine was estimated to be worth US$ 14250 million in 2023 and is forecast to a readjusted size of US$ 20410 million by 2030 with a CAGR of 5.3% during the forecast period 2024-2030

Mono Vaccine - Market

Mono Vaccine - Market

Mono vaccines reduce the number of shots your child needs while protecting against only one serious diseases
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Mono Vaccine, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Mono Vaccine by region & country, by Type, and by Application.
The Mono Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mono Vaccine.
Market Segmentation

Scope of Mono Vaccine - Market Report

Report Metric Details
Report Name Mono Vaccine - Market
Forecasted market size in 2030 US$ 20410 million
CAGR 5.3%
Forecasted years 2024 - 2030
Segment by Type:
Segment by Application
  • Adults
  • Children
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company GSK, Sanofi Pasteur, Merck, Pfizer, CNBG, Sanofi Pasteur MSD, Serum Institute of India, Biokangtai
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Mono Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Mono Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Mono Vaccine in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Mono Vaccine - Market size in 2030?

Ans: The Mono Vaccine - Market size in 2030 will be US$ 20410 million.

Who are the main players in the Mono Vaccine - Market report?

Ans: The main players in the Mono Vaccine - Market are GSK, Sanofi Pasteur, Merck, Pfizer, CNBG, Sanofi Pasteur MSD, Serum Institute of India, Biokangtai

What are the Application segmentation covered in the Mono Vaccine - Market report?

Ans: The Applications covered in the Mono Vaccine - Market report are Adults, Children

What are the Type segmentation covered in the Mono Vaccine - Market report?

Ans: The Types covered in the Mono Vaccine - Market report are Meningococcal Vaccine, Japanese Encephalitis Vaccine, Yellow Fever Vaccine, Hepatitis Vaccine, Cholera Vaccine, Other

Recommended Reports

Vaccine Products

Vaccine Packaging

Specialty Vaccines

1 Market Overview
1.1 Mono Vaccine Product Introduction
1.2 Global Mono Vaccine Market Size Forecast
1.2.1 Global Mono Vaccine Sales Value (2019-2030)
1.2.2 Global Mono Vaccine Sales Volume (2019-2030)
1.2.3 Global Mono Vaccine Sales Price (2019-2030)
1.3 Mono Vaccine Market Trends & Drivers
1.3.1 Mono Vaccine Industry Trends
1.3.2 Mono Vaccine Market Drivers & Opportunity
1.3.3 Mono Vaccine Market Challenges
1.3.4 Mono Vaccine Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Mono Vaccine Players Revenue Ranking (2023)
2.2 Global Mono Vaccine Revenue by Company (2019-2024)
2.3 Global Mono Vaccine Players Sales Volume Ranking (2023)
2.4 Global Mono Vaccine Sales Volume by Company Players (2019-2024)
2.5 Global Mono Vaccine Average Price by Company (2019-2024)
2.6 Key Manufacturers Mono Vaccine Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Mono Vaccine Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Mono Vaccine
2.9 Mono Vaccine Market Competitive Analysis
2.9.1 Mono Vaccine Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Mono Vaccine Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mono Vaccine as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Meningococcal Vaccine
3.1.2 Japanese Encephalitis Vaccine
3.1.3 Yellow Fever Vaccine
3.1.4 Hepatitis Vaccine
3.1.5 Cholera Vaccine
3.1.6 Other
3.2 Global Mono Vaccine Sales Value by Type
3.2.1 Global Mono Vaccine Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Mono Vaccine Sales Value, by Type (2019-2030)
3.2.3 Global Mono Vaccine Sales Value, by Type (%) (2019-2030)
3.3 Global Mono Vaccine Sales Volume by Type
3.3.1 Global Mono Vaccine Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Mono Vaccine Sales Volume, by Type (2019-2030)
3.3.3 Global Mono Vaccine Sales Volume, by Type (%) (2019-2030)
3.4 Global Mono Vaccine Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Adults
4.1.2 Children
4.2 Global Mono Vaccine Sales Value by Application
4.2.1 Global Mono Vaccine Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Mono Vaccine Sales Value, by Application (2019-2030)
4.2.3 Global Mono Vaccine Sales Value, by Application (%) (2019-2030)
4.3 Global Mono Vaccine Sales Volume by Application
4.3.1 Global Mono Vaccine Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Mono Vaccine Sales Volume, by Application (2019-2030)
4.3.3 Global Mono Vaccine Sales Volume, by Application (%) (2019-2030)
4.4 Global Mono Vaccine Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Mono Vaccine Sales Value by Region
5.1.1 Global Mono Vaccine Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Mono Vaccine Sales Value by Region (2019-2024)
5.1.3 Global Mono Vaccine Sales Value by Region (2025-2030)
5.1.4 Global Mono Vaccine Sales Value by Region (%), (2019-2030)
5.2 Global Mono Vaccine Sales Volume by Region
5.2.1 Global Mono Vaccine Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Mono Vaccine Sales Volume by Region (2019-2024)
5.2.3 Global Mono Vaccine Sales Volume by Region (2025-2030)
5.2.4 Global Mono Vaccine Sales Volume by Region (%), (2019-2030)
5.3 Global Mono Vaccine Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Mono Vaccine Sales Value, 2019-2030
5.4.2 North America Mono Vaccine Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Mono Vaccine Sales Value, 2019-2030
5.5.2 Europe Mono Vaccine Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Mono Vaccine Sales Value, 2019-2030
5.6.2 Asia Pacific Mono Vaccine Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Mono Vaccine Sales Value, 2019-2030
5.7.2 South America Mono Vaccine Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Mono Vaccine Sales Value, 2019-2030
5.8.2 Middle East & Africa Mono Vaccine Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Mono Vaccine Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Mono Vaccine Sales Value
6.2.1 Key Countries/Regions Mono Vaccine Sales Value, 2019-2030
6.2.2 Key Countries/Regions Mono Vaccine Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Mono Vaccine Sales Value, 2019-2030
6.3.2 United States Mono Vaccine Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Mono Vaccine Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Mono Vaccine Sales Value, 2019-2030
6.4.2 Europe Mono Vaccine Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Mono Vaccine Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Mono Vaccine Sales Value, 2019-2030
6.5.2 China Mono Vaccine Sales Value by Type (%), 2023 VS 2030
6.5.3 China Mono Vaccine Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Mono Vaccine Sales Value, 2019-2030
6.6.2 Japan Mono Vaccine Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Mono Vaccine Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Mono Vaccine Sales Value, 2019-2030
6.7.2 South Korea Mono Vaccine Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Mono Vaccine Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Mono Vaccine Sales Value, 2019-2030
6.8.2 Southeast Asia Mono Vaccine Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Mono Vaccine Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Mono Vaccine Sales Value, 2019-2030
6.9.2 India Mono Vaccine Sales Value by Type (%), 2023 VS 2030
6.9.3 India Mono Vaccine Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 GSK
7.1.1 GSK Company Information
7.1.2 GSK Introduction and Business Overview
7.1.3 GSK Mono Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.1.4 GSK Mono Vaccine Product Offerings
7.1.5 GSK Recent Development
7.2 Sanofi Pasteur
7.2.1 Sanofi Pasteur Company Information
7.2.2 Sanofi Pasteur Introduction and Business Overview
7.2.3 Sanofi Pasteur Mono Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Sanofi Pasteur Mono Vaccine Product Offerings
7.2.5 Sanofi Pasteur Recent Development
7.3 Merck
7.3.1 Merck Company Information
7.3.2 Merck Introduction and Business Overview
7.3.3 Merck Mono Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Merck Mono Vaccine Product Offerings
7.3.5 Merck Recent Development
7.4 Pfizer
7.4.1 Pfizer Company Information
7.4.2 Pfizer Introduction and Business Overview
7.4.3 Pfizer Mono Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Pfizer Mono Vaccine Product Offerings
7.4.5 Pfizer Recent Development
7.5 CNBG
7.5.1 CNBG Company Information
7.5.2 CNBG Introduction and Business Overview
7.5.3 CNBG Mono Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.5.4 CNBG Mono Vaccine Product Offerings
7.5.5 CNBG Recent Development
7.6 Sanofi Pasteur MSD
7.6.1 Sanofi Pasteur MSD Company Information
7.6.2 Sanofi Pasteur MSD Introduction and Business Overview
7.6.3 Sanofi Pasteur MSD Mono Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Sanofi Pasteur MSD Mono Vaccine Product Offerings
7.6.5 Sanofi Pasteur MSD Recent Development
7.7 Serum Institute of India
7.7.1 Serum Institute of India Company Information
7.7.2 Serum Institute of India Introduction and Business Overview
7.7.3 Serum Institute of India Mono Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Serum Institute of India Mono Vaccine Product Offerings
7.7.5 Serum Institute of India Recent Development
7.8 Biokangtai
7.8.1 Biokangtai Company Information
7.8.2 Biokangtai Introduction and Business Overview
7.8.3 Biokangtai Mono Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Biokangtai Mono Vaccine Product Offerings
7.8.5 Biokangtai Recent Development
8 Industry Chain Analysis
8.1 Mono Vaccine Industrial Chain
8.2 Mono Vaccine Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Mono Vaccine Sales Model
8.5.2 Sales Channel
8.5.3 Mono Vaccine Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Mono Vaccine Market Trends
    Table 2. Mono Vaccine Market Drivers & Opportunity
    Table 3. Mono Vaccine Market Challenges
    Table 4. Mono Vaccine Market Restraints
    Table 5. Global Mono Vaccine Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Mono Vaccine Revenue Market Share by Company (2019-2024)
    Table 7. Global Mono Vaccine Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global Mono Vaccine Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Mono Vaccine Price by Company (2019-2024) & (USD/Unit)
    Table 10. Key Manufacturers Mono Vaccine Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Mono Vaccine Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Mono Vaccine
    Table 13. Global Mono Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mono Vaccine as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Mono Vaccine Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Mono Vaccine Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Mono Vaccine Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Mono Vaccine Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Mono Vaccine Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Mono Vaccine Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global Mono Vaccine Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global Mono Vaccine Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global Mono Vaccine Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Mono Vaccine Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Mono Vaccine Price by Type (2019-2024) & (USD/Unit)
    Table 27. Global Mono Vaccine Price by Type (2025-2030) & (USD/Unit)
    Table 28. Global Mono Vaccine Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Mono Vaccine Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Mono Vaccine Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Mono Vaccine Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Mono Vaccine Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Mono Vaccine Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global Mono Vaccine Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global Mono Vaccine Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global Mono Vaccine Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Mono Vaccine Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Mono Vaccine Price by Application (2019-2024) & (USD/Unit)
    Table 39. Global Mono Vaccine Price by Application (2025-2030) & (USD/Unit)
    Table 40. Global Mono Vaccine Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Mono Vaccine Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Mono Vaccine Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Mono Vaccine Sales Value by Region (2019-2024) & (%)
    Table 44. Global Mono Vaccine Sales Value by Region (2025-2030) & (%)
    Table 45. Global Mono Vaccine Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global Mono Vaccine Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global Mono Vaccine Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global Mono Vaccine Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Mono Vaccine Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Mono Vaccine Average Price by Region (2019-2024) & (USD/Unit)
    Table 51. Global Mono Vaccine Average Price by Region (2025-2030) & (USD/Unit)
    Table 52. Key Countries/Regions Mono Vaccine Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Mono Vaccine Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Mono Vaccine Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Mono Vaccine Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions Mono Vaccine Sales Volume, (2025-2030) & (K Units)
    Table 57. GSK Company Information
    Table 58. GSK Introduction and Business Overview
    Table 59. GSK Mono Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 60. GSK Mono Vaccine Product Offerings
    Table 61. GSK Recent Development
    Table 62. Sanofi Pasteur Company Information
    Table 63. Sanofi Pasteur Introduction and Business Overview
    Table 64. Sanofi Pasteur Mono Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 65. Sanofi Pasteur Mono Vaccine Product Offerings
    Table 66. Sanofi Pasteur Recent Development
    Table 67. Merck Company Information
    Table 68. Merck Introduction and Business Overview
    Table 69. Merck Mono Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 70. Merck Mono Vaccine Product Offerings
    Table 71. Merck Recent Development
    Table 72. Pfizer Company Information
    Table 73. Pfizer Introduction and Business Overview
    Table 74. Pfizer Mono Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 75. Pfizer Mono Vaccine Product Offerings
    Table 76. Pfizer Recent Development
    Table 77. CNBG Company Information
    Table 78. CNBG Introduction and Business Overview
    Table 79. CNBG Mono Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 80. CNBG Mono Vaccine Product Offerings
    Table 81. CNBG Recent Development
    Table 82. Sanofi Pasteur MSD Company Information
    Table 83. Sanofi Pasteur MSD Introduction and Business Overview
    Table 84. Sanofi Pasteur MSD Mono Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 85. Sanofi Pasteur MSD Mono Vaccine Product Offerings
    Table 86. Sanofi Pasteur MSD Recent Development
    Table 87. Serum Institute of India Company Information
    Table 88. Serum Institute of India Introduction and Business Overview
    Table 89. Serum Institute of India Mono Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 90. Serum Institute of India Mono Vaccine Product Offerings
    Table 91. Serum Institute of India Recent Development
    Table 92. Biokangtai Company Information
    Table 93. Biokangtai Introduction and Business Overview
    Table 94. Biokangtai Mono Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 95. Biokangtai Mono Vaccine Product Offerings
    Table 96. Biokangtai Recent Development
    Table 97. Key Raw Materials Lists
    Table 98. Raw Materials Key Suppliers Lists
    Table 99. Mono Vaccine Downstream Customers
    Table 100. Mono Vaccine Distributors List
    Table 101. Research Programs/Design for This Report
    Table 102. Key Data Information from Secondary Sources
    Table 103. Key Data Information from Primary Sources
List of Figures
    Figure 1. Mono Vaccine Product Picture
    Figure 2. Global Mono Vaccine Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Mono Vaccine Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Mono Vaccine Sales Volume (2019-2030) & (K Units)
    Figure 5. Global Mono Vaccine Sales Price (2019-2030) & (USD/Unit)
    Figure 6. Mono Vaccine Report Years Considered
    Figure 7. Global Mono Vaccine Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Mono Vaccine Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Mono Vaccine Revenue in 2023
    Figure 10. Mono Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Meningococcal Vaccine Picture
    Figure 12. Japanese Encephalitis Vaccine Picture
    Figure 13. Yellow Fever Vaccine Picture
    Figure 14. Hepatitis Vaccine Picture
    Figure 15. Cholera Vaccine Picture
    Figure 16. Other Picture
    Figure 17. Global Mono Vaccine Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 18. Global Mono Vaccine Sales Value Market Share by Type, 2023 & 2030
    Figure 19. Global Mono Vaccine Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 20. Global Mono Vaccine Sales Volume Market Share by Type, 2023 & 2030
    Figure 21. Global Mono Vaccine Price by Type (2019-2030) & (USD/Unit)
    Figure 22. Product Picture of Adults
    Figure 23. Product Picture of Children
    Figure 24. Global Mono Vaccine Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 25. Global Mono Vaccine Sales Value Market Share by Application, 2023 & 2030
    Figure 26. Global Mono Vaccine Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 27. Global Mono Vaccine Sales Volume Market Share by Application, 2023 & 2030
    Figure 28. Global Mono Vaccine Price by Application (2019-2030) & (USD/Unit)
    Figure 29. North America Mono Vaccine Sales Value (2019-2030) & (US$ Million)
    Figure 30. North America Mono Vaccine Sales Value by Country (%), 2023 VS 2030
    Figure 31. Europe Mono Vaccine Sales Value (2019-2030) & (US$ Million)
    Figure 32. Europe Mono Vaccine Sales Value by Country (%), 2023 VS 2030
    Figure 33. Asia Pacific Mono Vaccine Sales Value (2019-2030) & (US$ Million)
    Figure 34. Asia Pacific Mono Vaccine Sales Value by Country (%), 2023 VS 2030
    Figure 35. South America Mono Vaccine Sales Value (2019-2030) & (US$ Million)
    Figure 36. South America Mono Vaccine Sales Value by Country (%), 2023 VS 2030
    Figure 37. Middle East & Africa Mono Vaccine Sales Value (2019-2030) & (US$ Million)
    Figure 38. Middle East & Africa Mono Vaccine Sales Value by Country (%), 2023 VS 2030
    Figure 39. Key Countries/Regions Mono Vaccine Sales Value (%), (2019-2030)
    Figure 40. Key Countries/Regions Mono Vaccine Sales Volume (%), (2019-2030)
    Figure 41. United States Mono Vaccine Sales Value, (2019-2030) & (US$ Million)
    Figure 42. United States Mono Vaccine Sales Value by Type (%), 2023 VS 2030
    Figure 43. United States Mono Vaccine Sales Value by Application (%), 2023 VS 2030
    Figure 44. Europe Mono Vaccine Sales Value, (2019-2030) & (US$ Million)
    Figure 45. Europe Mono Vaccine Sales Value by Type (%), 2023 VS 2030
    Figure 46. Europe Mono Vaccine Sales Value by Application (%), 2023 VS 2030
    Figure 47. China Mono Vaccine Sales Value, (2019-2030) & (US$ Million)
    Figure 48. China Mono Vaccine Sales Value by Type (%), 2023 VS 2030
    Figure 49. China Mono Vaccine Sales Value by Application (%), 2023 VS 2030
    Figure 50. Japan Mono Vaccine Sales Value, (2019-2030) & (US$ Million)
    Figure 51. Japan Mono Vaccine Sales Value by Type (%), 2023 VS 2030
    Figure 52. Japan Mono Vaccine Sales Value by Application (%), 2023 VS 2030
    Figure 53. South Korea Mono Vaccine Sales Value, (2019-2030) & (US$ Million)
    Figure 54. South Korea Mono Vaccine Sales Value by Type (%), 2023 VS 2030
    Figure 55. South Korea Mono Vaccine Sales Value by Application (%), 2023 VS 2030
    Figure 56. Southeast Asia Mono Vaccine Sales Value, (2019-2030) & (US$ Million)
    Figure 57. Southeast Asia Mono Vaccine Sales Value by Type (%), 2023 VS 2030
    Figure 58. Southeast Asia Mono Vaccine Sales Value by Application (%), 2023 VS 2030
    Figure 59. India Mono Vaccine Sales Value, (2019-2030) & (US$ Million)
    Figure 60. India Mono Vaccine Sales Value by Type (%), 2023 VS 2030
    Figure 61. India Mono Vaccine Sales Value by Application (%), 2023 VS 2030
    Figure 62. Mono Vaccine Industrial Chain
    Figure 63. Mono Vaccine Manufacturing Cost Structure
    Figure 64. Channels of Distribution (Direct Sales, and Distribution)
    Figure 65. Bottom-up and Top-down Approaches for This Report
    Figure 66. Data Triangulation
    Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India

SIMILAR REPORTS